Otezla Now Approved for Plaque Psoriasis Across All Severities

The FDA has approved Otezla (apremilast) to treat adults with plaque psoriasis across all severities, including mild, moderate, and severe.

Related Keywords

Davidm Reese , ,Amgen ,Drug Administration ,Global Assessment ,Whole Body Itch Numeric Rating Scale ,Scalp Physician Global Assessment ,Accessed December ,